Download FREE Report Sample
Download Free sampleA?hospital-acquired infection?(HAI) is an?infection?whose development is favoured by a?hospital?environment, such as one?acquired?by a patient during a?hospital?visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infection (UTI), and surgical site infection (SSI). Antifungal therapy (eg, fluconazole, caspofungin, voriconazole, amphotericin B) in some cases are added to empiric antibiotic coverage. Antiviral therapy (eg, ganciclovir, acyclovir) can be used in the treatment of suspected disseminated viral infections.
Hospital Acquired Infections Drugs Market contains market size and forecasts of Hospital Acquired Infections Drugs in Global, including the following market information:
Global Hospital Acquired Infections Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hospital Acquired Infections Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibacterial Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hospital Acquired Infections Drugs include Merck, Pfizer, Bayer, GlaxoSmithKline, Daiichi Sankyo, AbbVie, Abbott Laboratories, Roche and Jiangsu Hengrui Medicine and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hospital Acquired Infections Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital Acquired Infections Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hospital Acquired Infections Drugs Market Segment Percentages, by Type, 2021 (%)
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Global Hospital Acquired Infections Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hospital Acquired Infections Drugs Market Segment Percentages, by Application, 2021 (%)
Urinary Tract Infections
Ventilator-associated Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections
Global Hospital Acquired Infections Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hospital Acquired Infections Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital Acquired Infections Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hospital Acquired Infections Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Pfizer
Bayer
GlaxoSmithKline
Daiichi Sankyo
AbbVie
Abbott Laboratories
Roche
Jiangsu Hengrui Medicine
Eli Lilly
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
